Literature DB >> 7298638

A plasma inhibitor of triglyceride and cholesteryl ester transfer activities.

R E Morton, D B Zilversmit.   

Abstract

An inhibitor of triglyceride and cholesteryl ester transfer activities has been identified in the plasmas of several animal species. The inhibitor in human plasma has been separated from lipid transfer protein by chromatography on phenyl-Sepharose and CM-cellulose. The inhibitor is characterized as a protein with Mr approximately 35,000 and an isoelectric point of 4 or less. The inhibitor protein decreased the transfer of both triglyceride and cholesteryl ester between all pairs of very low, low, and high density lipoproteins. Although under most conditions the inhibition of triglyceride and cholesteryl ester transfer was similar, the degree of inhibition of lipid transfer was dependent on the lipoprotein pair studied.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7298638

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Biochemical characterization of cholesteryl ester transfer protein inhibitors.

Authors:  Mollie Ranalletta; Kathleen K Bierilo; Ying Chen; Denise Milot; Qing Chen; Elaine Tung; Caroline Houde; Nadine H Elowe; Margarita Garcia-Calvo; Gene Porter; Suzanne Eveland; Betsy Frantz-Wattley; Mike Kavana; George Addona; Peter Sinclair; Carl Sparrow; Edward A O'Neill; Ken S Koblan; Ayesha Sitlani; Brian Hubbard; Timothy S Fisher
Journal:  J Lipid Res       Date:  2010-05-10       Impact factor: 5.922

2.  The lipid transfer properties of CETP define the concentration and composition of plasma lipoproteins.

Authors:  Richard E Morton; Yan Liu
Journal:  J Lipid Res       Date:  2020-06-26       Impact factor: 5.922

3.  Conversion of lipid transfer inhibitor protein (apolipoprotein F) to its active form depends on LDL composition.

Authors:  Richard E Morton; Diane J Greene
Journal:  J Lipid Res       Date:  2011-09-21       Impact factor: 5.922

4.  Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism.

Authors:  Yan Liu; Richard E Morton
Journal:  Curr Opin Lipidol       Date:  2020-08       Impact factor: 4.776

5.  Raman imaging of macrophages incubated with triglyceride-enriched oxLDL visualizes translocation of lipids between endocytic vesicles and lipid droplets.

Authors:  Clara Stiebing; Lisa Schmölz; Maria Wallert; Christian Matthäus; Stefan Lorkowski; Jürgen Popp
Journal:  J Lipid Res       Date:  2017-01-31       Impact factor: 5.922

Review 6.  Interaction of lipid transfer protein with plasma lipoproteins and cell membranes.

Authors:  R E Morton
Journal:  Experientia       Date:  1990-06-15

7.  Modification of CETP function by changing its substrate preference: a new paradigm for CETP drug design.

Authors:  Richard E Morton; Lahoucine Izem
Journal:  J Lipid Res       Date:  2015-01-23       Impact factor: 5.922

8.  Transfer of phosphatidylcholine, phosphatidylethanolamine and sphingomyelin from low- and high-density lipoprotein to human platelets.

Authors:  B Engelmann; C Kögl; R Kulschar; B Schaipp
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

9.  Cholesteryl ester transfer proteins from different species do not have equivalent activities.

Authors:  Richard E Morton; Lahoucine Izem
Journal:  J Lipid Res       Date:  2013-12-01       Impact factor: 5.922

10.  Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver.

Authors:  E M Quinet; L B Agellon; P A Kroon; Y L Marcel; Y C Lee; M E Whitlock; A R Tall
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.